Amneal Completes Hat Trick With Delayed $2.6bn US Pegfilgrastim Entry

Developed With Kashiv BioSciences, Fylnetra Is Sixth Biosimilar On The Market

 
• By Dean Rudge
  
kentoh/Shutterstock.com
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products